Mink Therapeutics Inc（INKT）价格预测INKTMink Therapeutics Inc

Alphio's INKT stock price prediction model matches the current Mink Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.06 (+1.02%). The 1-week path is $11.22 (+2.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Mink Therapeutics Inc (INKT) is currently not a strong buy due to its recent performance and financial metrics. The stock is trading at $11.43, and the RSI is at 46.944, indicating a neutral momentum. The company reported a net loss of $3.1 million in Q2 2026, which is significant, and the forward P/E ratio is currently 0, reflecting uncertainty in future earnings. Additionally, insider selling has increased by 432.67% over the last month, which raises concerns about insider confidence in the stock's future performance. The main risk is the ongoing negative earnings trend, with EPS reported at -0.62 for Q2 2026, suggesting continued financial challenges. Overall, while there are some positive developments in clinical trials, the financial instability and insider selling suggest a cautious approach for long-term investors.

Mink Therapeutics Inc (INKT) last closed at $10.95, losing -1.26%. These facts feed the 1-day and 1-week INKT price prediction above.